Through the 90-day period concluding February 19, 2026, Vertex Pharmaceuticals's top three insider stakeholders include Ceo & President Reshma Kewalramani (146.53K shares), Evp Chief Patient & Ext Af Off Amit Sachdev (68.94K shares), Evp And Coo Stuart A Arbuckle (63.37K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Reshma Kewalramani | Ceo & President | 146,528 | 12 Feb, 2026 |
| Amit Sachdev | Evp Chief Patient & Ext Af Off | 68,941 | 12 Feb, 2026 |
| Stuart A Arbuckle | Evp And Coo | 63,368 | 02 Jul, 2025 |
| Ourania Tatsis | Evp And Chief Reg. & Quality Off. | 51,436 | 12 Feb, 2026 |
| Charles F Jr Wagner | Evp And Co & Fo | 48,280 | 12 Feb, 2026 |
| Bruce I Sachs | 45,000 | 07 Aug, 2025 | |
| Carmen Bozic | Evp And Cmo | 41,857 | 12 Feb, 2026 |
| David Altshuler | Evp And Chief Scientific Officer | 34,477 | 26 Jan, 2026 |
| Jeffrey M Leiden | Executive Chairman | 33,039 | 26 Jan, 2026 |
| Bastiano Sanna | Evp And Cell & Genetic Therapies | 32,038 | 09 May, 2023 |
| Edward Morrow Iii Atkinson | Evp And Chief Technical Ops. Off. | 22,046 | 12 Feb, 2026 |
| Duncan Mckechnie | Evp And Chief Commercial Officer | 21,811 | 12 Feb, 2026 |
| Jonathan Biller | Evp And Chief Legal Officer | 20,819 | 12 Feb, 2026 |
| Mark E. Bunnage | Evp And Chief Scientific Officer | 12,914 | 12 Feb, 2026 |
| Kristen Ambrose | Svp & Chief Accounting Officer | 10,127 | 12 Feb, 2026 |
| Joy Liu | Svp And General Counsel | 9,605 | 17 Aug, 2022 |
| Alan M Garber | 6,872 | 05 May, 2025 | |
| Terrence C Kearney | 6,536 | 14 Aug, 2023 | |
| Lloyd Carney | 6,315 | 20 Nov, 2025 | |
| Sangeeta N. Bhatia | 4,565 | 29 Aug, 2025 | |
| Suketu Upadhyay | 2,354 | 05 May, 2025 | |
| Diana Mckenzie | 2,231 | 05 May, 2025 | |
| Nancy Thornberry | 2,035 | 05 May, 2025 | |
| Yuchun Lee | 1,875 | 31 Jan, 2023 | |
| Jennifer Schneider | 1,718 | 05 May, 2025 | |
| Michel Lagarde | 1,132 | 10 Oct, 2023 | |
| Margaret G Mcglynn | 178 | 03 May, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Feb, 2026 | Jonathan Biller | Common Stock | D | 1,925 | $460.43 | 20,819 | D | S |
| 11 Feb, 2026 | Ourania Tatsis | Common Stock | D | 466 | $460.43 | 51,436 | D | S |
| 11 Feb, 2026 | Kristen Ambrose | Common Stock | D | 1,376 | $460.43 | 10,127 | D | S |
| 11 Feb, 2026 | Edward Morrow Iii Atkinson | Common Stock | D | 1,751 | $460.43 | 22,046 | D | S |
| 11 Feb, 2026 | Mark E. Bunnage | Common Stock | D | 2,021 | $460.43 | 12,914 | D | S |
| 10 Feb, 2026 | Charles F Jr Wagner | Common Stock | D | 3,045 | $468.41 | 48,280 | D | F |
| 10 Feb, 2026 | Amit Sachdev | Common Stock | D | 2,057 | $468.41 | 68,941 | D | F |
| 10 Feb, 2026 | Reshma Kewalramani | Common Stock | D | 8,297 | $468.41 | 146,528 | D | F |
| 10 Feb, 2026 | Jonathan Biller | Common Stock | D | 1,630 | $468.41 | 22,744 | D | F |
| 10 Feb, 2026 | Ourania Tatsis | Common Stock | D | 2,140 | $468.41 | 51,902 | D | F |
| 10 Feb, 2026 | Carmen Bozic | Common Stock | D | 2,145 | $468.41 | 41,857 | D | F |
| 10 Feb, 2026 | Kristen Ambrose | Common Stock | D | 592 | $468.41 | 11,503 | D | F |
| 10 Feb, 2026 | Edward Morrow Iii Atkinson | Common Stock | D | 872 | $468.41 | 23,797 | D | F |
| 10 Feb, 2026 | Duncan Mckechnie | Common Stock | D | 1,127 | $468.41 | 21,811 | D | F |
| 10 Feb, 2026 | Mark E. Bunnage | Common Stock | D | 1,127 | $468.41 | 14,935 | D | F |
| 22 Jan, 2026 | Charles F Jr Wagner | Common Stock | A | 4,160 | $0.00 | 51,325 | D | A |
| 22 Jan, 2026 | Charles F Jr Wagner | Common Stock | A | 9,440 | $0.00 | 47,165 | D | A |
| 22 Jan, 2026 | Jeffrey M Leiden | Common Stock | A | 9,012 | $0.00 | 33,039 | D | A |
| 22 Jan, 2026 | Amit Sachdev | Common Stock | A | 7,866 | $0.00 | 67,115 | D | A |
| 22 Jan, 2026 | Amit Sachdev | Common Stock | A | 3,883 | $0.00 | 70,998 | D | A |